HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.

AbstractOBJECTIVES:
Vascular endothelial growth factors A and B (VEGF-A and VEGF-B) play a major role in angiogenesis and activate VEGF receptor 1 (VEGFR-1). However, the clinicopathologic and clinical value of VEGF-B and VEGFR-1 in invasive breast carcinoma remains unclear.
METHODS:
We immunohistochemically examined the expression pattern of VEGF-A, VEGF-B and VEGFR-1 in 177 invasive breast carcinomas in relation to clinicopathological parameters, p53, c-erbB2 proteins expression and patients' survival.
RESULTS:
VEGF-A, VEGF-B and VEGFR-1 were immunodetected predominantly in the cytoplasm of the malignant cells. None of the studied markers correlated with any of the clinicopathological parameters, other than stromal VEGFR-1 which inversely correlated with PR (p=0.021). Cancerous VEGF-A and stromal VEGFR-1 were positively related to p53 (p=0.016 and p=0.033, respectively). Cancerous VEGF-B was positively associated with c-erbB-2 (p=0.045) and was found to exert an unfavorable impact on both disease-free and the overall survival of the node-positive patients (p=0.05 and p=0.029, respectively). Cancerous VEGFR-1 was recognized as being an independent poor prognostic indicator (p=0.037).
CONCLUSION:
These findings suggest that, while VEGF-B seems to be useful as a prognostic indicator only in node-positive patients, VEGFR-1 may be an independent poor prognosticator in patients with invasive breast carcinoma.
AuthorsEleni Mylona, Paraskevi Alexandrou, Ioanna Giannopoulou, George Liapis, Markaki Sofia, Antonios Keramopoulos, Lydia Nakopoulou
JournalGynecologic oncology (Gynecol Oncol) Vol. 104 Issue 3 Pg. 557-63 (Mar 2007) ISSN: 0090-8258 [Print] United States
PMID17150246 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • VEGFA protein, human
  • VEGFB protein, human
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor B
  • Receptor, ErbB-2
  • Vascular Endothelial Growth Factor Receptor-1
Topics
  • Breast Neoplasms (metabolism, pathology)
  • Female
  • Humans
  • Immunohistochemistry
  • Neoplasm Invasiveness
  • Predictive Value of Tests
  • Prognosis
  • Receptor, ErbB-2 (biosynthesis)
  • Tumor Suppressor Protein p53 (biosynthesis)
  • Vascular Endothelial Growth Factor A (biosynthesis)
  • Vascular Endothelial Growth Factor B (biosynthesis)
  • Vascular Endothelial Growth Factor Receptor-1 (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: